glp-1 medications long term side effects Infographic GLP-1 Medications: Separating Fact from

Plasma (1,500 g , 3 min, 4C) was stored at 80C until analysis

Diabetes 64 , 819827 (2015)

Participants completed original and adapted forms of validated assessments (see Supplemental document)

Who Should Consider GLP-1 Therapy FDA indications for weight loss require: BMI 30 (obesity), or BMI 27 (overweight) with at least one weight-related condition hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea, cardiovascular disease, or similar These thresholds set eligibility, but they don't answer the more important question: who benefits most

And if you're looking for weight loss support yourself, your best first step is always to speak to your GP or registered healthcare professional who can point you in the right direction